Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$8.70 – $15.29
96% from low
No one on the platform currently holds MNMD.
No tracked institution reports a position in MNMD as of their last filing.
| Execution date | Ratio |
|---|---|
| 2022-08-29 | 1-for-15reverse |
No one on the platform has traded MNMD yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $17M | +1011.1% | $-3.01 | $-3.72–$-1.80 | — | 9 |
| 2027 | $28M | +70.7% | $-1.76 | $-2.24–$-0.51 | — | 12 |
| 2028 | $245M | +762.2% | $-0.78 | $-2.75–$4.28 | — | 10 |
| 2029 | $568M | +131.6% | $0.90 | $0.90–$0.90 | 16.7× | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-03-05 | $-0.48 | $-0.51 | -6.3% |
| 2025-11-06 | $-0.52 | $-0.78 | -50.0% |
| 2025-07-31 | $-0.38 | $-0.50 | -31.6% |
| 2025-05-08 | $-0.36 | $-0.35 | +2.8% |
| 2025-03-06 | $-0.33 | $-0.41 | -24.2% |
| 2024-11-07 | $-0.29 | $-0.27 | +6.9% |
| 2024-08-13 | $-0.30 | $-0.48 | -60.0% |
| 2024-05-08 | $-0.66 |
| $-0.60 |
| +9.1% |
| $387M |
| — |
| FBIOFortress Biotech, Inc. | $2.75 | +5.36% | $91M | — |
| GHRSGH Research PLC | $30.24 | +3.99% | $2.1B | — |
Source: Financial Modeling Prep · peers by sector/industry